Natco Pharma Limited has informed the Exchange about Revised intimation earnings call for the quarter and half year ended 30th September, 2025
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Natco Pharma has shared a revised intimation regarding its earnings conference call for the quarter and half year ended 30th September 2025. This means the company has updated the previously communicated date, time, or dial-in details for the call where management will discuss Q2 and H1 FY26 results. The filing itself does not contain any financial numbers, business updates, or material developments. It is a procedural/corporate governance communication informing investors and analysts about the change in the earnings call schedule. Investors and analysts who plan to attend the call should check the revised details carefully.
This is a routine housekeeping announcement with no direct impact on the stock price or fundamentals. Shareholders and analysts should simply note the updated call details to ensure they can join and hear management's commentary on the September quarter results.